Pacira Biosciences, INC Form 4 insider transactions

Chief Operating Officer of Pacira BioSciences, Daryl Gaugler, reports a transaction involving common stock to cover tax withholding obligations.

Jonathan Slonin, Chief Medical Officer of Pacira BioSciences, reports the disposal of 1,615 shares to cover tax obligations upon vesting of a restricted stock unit award.

Director Gary W. Pace of Pacira BioSciences, Inc. reported selling a significant number of shares in a series of transactions between March 6 and March 8, 2024.